Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 29771293.
- Also identified by DOI 10.1093/cid/ciy406 and PMC identifier 6454429.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We retrospectively assessed breakthrough invasive fungal infections (b-IFIs) in 100 consecutive patients with leukemia receiving single-agent isavuconazole; 13 had documented b-IFIs (candidiasis in 6, mucormycosis in 4). All b-IFIs were observed in patients with prolonged neutropenia and active leukemia.
Medical subject headings
- Antifungal Agents
- Invasive Fungal Infections
- Leukemia
- Nitriles
- Pyridines
- Triazoles